Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD Meeting Abstract
| Authors: | Senkus-Konefka, E.; Domchek, S. M.; Im, S. A.; Xu, B.; Armstrong, A.; Masuda, N.; Delaloge, S.; Li, W.; Tung, N.; Conte, P.; Wu, W.; Goessl, C.; Runswick, S.; Robson, M. |
| Abstract Title: | Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD |
| Meeting Title: | 11th European Breast Cancer Conference (EBCC-11) |
| Journal Title: | European Journal of Cancer |
| Volume: | 92 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2018 Mar 21-23 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2018-04-01 |
| Start Page: | S19 |
| End Page: | S20 |
| Language: | English |
| ACCESSION: | WOS:000429103100027 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(18)30285-5 |
| Notes: | Meeting Abstract: 101 (PB-002) -- Source: Wos |
